<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JCDSA</journal-id><journal-title-group><journal-title>Journal of Cosmetics, Dermatological Sciences and Applications</journal-title></journal-title-group><issn pub-type="epub">2161-4105</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jcdsa.2021.111006</article-id><article-id pub-id-type="publisher-id">JCDSA-108071</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Clinical Evaluation after Introduction of Stem Cell Supernatant Biocell Shot 65 by Electroporation
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ryusuke</surname><given-names>Suzuki</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Harue</surname><given-names>Suzuki</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maki</surname><given-names>Yokogawa</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Junichi</surname><given-names>Motohashi</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Division of Life Science and Engineering, School of Science and Engineering, Tokyo Denki University, Saitama, Japan</addr-line></aff><aff id="aff4"><addr-line>Pure Code Inc., Osaka, Japan</addr-line></aff><aff id="aff3"><addr-line>Yokogawa Dermatological Clinic, Kochi, Japan</addr-line></aff><aff id="aff2"><addr-line>Suzuki Plastic Surgery Clinic, Kyoto, Japan</addr-line></aff><pub-date pub-type="epub"><day>03</day><month>03</month><year>2021</year></pub-date><volume>11</volume><issue>01</issue><fpage>58</fpage><lpage>70</lpage><history><date date-type="received"><day>27,</day>	<month>January</month>	<year>2021</year></date><date date-type="rev-recd"><day>27,</day>	<month>March</month>	<year>2021</year>	</date><date date-type="accepted"><day>30,</day>	<month>March</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objectives
  :
   The objective of this study is clinical evaluation after introduction of stem cell supernatant Biocell Shot 65 by electroporation. <b>Background:</b>
   There is a clinical report of psoriasis treatment by umbilical cord blood-derived stem cells, in which there was a beneficial result. These clinical results are the result of cord blood-derived cell growth factors. The umbilical cord blood-derived stem cell culture supernatant contains a high amount of TGF-β, PDGA, etc., and promotes wound healing. In addition, we suppose that the supernatant has the esthetic effect of improving skin condition, thus, we planned to make a clinical evaluation. However, it is difficult to set judgement criteria, and human judgement tends to be subjective. Therefore, in this study, as a new clinical evaluator, we used an AI skin diagnostic device with learning function. <b>Methods:</b> Stem cell culture supernatant Biocell Shot 65 was used as an introduction solution. After it was applied to the full faces of four patients, electroporation with BeBe pinocchio DM-5 SUPER DX Plus promoted infiltration deep in the keratinized layer. The patients were all healthy women in their forties. This procedure was performed every two weeks for three months. Wrinkles, fine lines around eyes, stains, pores, and 4V, which is considered as one diagnostic criteria, were evaluated at baseline and after each procedure with the skin diagnostic device HiMirror-Professional. In this study, macroscopic findings were not examined. <b>Results:</b> In all four patients, 4V did not change remarkably. Patient 1 showed improvement after the procedure in wrinkles, fine lines around eyes, stains, and pores. Patient 2 revealed improvement only in fine lines around eyes, but did not show improvement in other items. Patient 3 improved in wrinkles, stains, and pores only after the second procedure, but did not show improvement in the other procedures. Patient 4 improved in all items except 4V after the fourth procedure. In addition, when the mean values of all the patients were plotted and compared before and after each procedure, there was a trend toward improvements after the fifth procedure. <b>Conclusion:</b> In addition to application of supernatant culture to the skin, introduction of the solution to the skin by electroporation might improve stains, wrinkles, and pores. Our evaluation was performed with a facial diagnostic device three months after the start of the procedure.
 
</p></abstract><kwd-group><kwd>Clinical Evaluation</kwd><kwd> Stem Cell</kwd><kwd> Skin Treatment</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>There is a clinical report about umbilical cord blood-derived stem cell treatment for a patient with psoriatic arthritis, the result of which was beneficial [<xref ref-type="bibr" rid="scirp.108071-ref1">1</xref>]. Margaret Coutts et al. conclude that stem cells in umbilical cord blood support tissue repair and suppress over-inflammation. There is another report about tissue repair support and over-inflammation suppression by umbilical cord blood-derived stem cells [<xref ref-type="bibr" rid="scirp.108071-ref2">2</xref>]. It is a well-known fact that umbilical cord blood-derived stem cells have some effects in the body. Cells in the body produce many cell growth factors for cell growth, cell migration, and immunosuppression, etc. Various treatments by cell growth factors are applied in clinical and esthetic practice based on this principle [<xref ref-type="bibr" rid="scirp.108071-ref3">3</xref>]. Transdermal application of one of the growth factors or direct introduction to the wound site stimulates the body’s healing abilities, and is beneficial even in persistent injury such as intractable skin ulcer. Many cell growth factor agents, however, use a single growth factor, and they do not sufficiently affect the wound site due to protease in the wound site or absorption by gauze. Therefore, several applications to the wound site are required per day. Kuroyanagi et al. used a wound dressing made of hyaluronic acid and collagen with EGF in order to prevent inactivation of growth factors by degrading enzymes. This dressing decreased the number of applications and the financial burden of the patients, and improved wound healing [<xref ref-type="bibr" rid="scirp.108071-ref4">4</xref>]. Based on these reports, we supposed that cell growth factors in umbilical cord blood-derived stem cells would support tissue repair and suppress over-inflammation. In order to use these growth factor agents on a daily basis, they should be used as a cosmetic. Patients can take care of their skin daily at home, and non-severe skin damage such as photoaging can be handled effectively by cosmetics. Mesenchymal stem cells are pluripotent cells, which originate in various tissues such as bone marrow, fat tissue, and umbilical cord blood. We used umbilical cord blood-derived mesenchymal stem cells because they have more biological advantages than other Mesenchymal stem cells [<xref ref-type="bibr" rid="scirp.108071-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.108071-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.108071-ref7">7</xref>]. Mesenchymal stem cells are essential for regeneration of the skin, so they are the most important cells for the skin [<xref ref-type="bibr" rid="scirp.108071-ref8">8</xref>]. Recent studies suggested that Mesenchymal stem cells stimulate human dermal fibroblasts through a paracrine mechanism, and promote the wound healing in the skin [<xref ref-type="bibr" rid="scirp.108071-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.108071-ref10">10</xref>]. Mesenchymal stem cells secrete many cytokines and growth factors such as epidermal growth factor (EGF), fibroblast growth factor (bFGF), and transforming growth factor β (TGF-β). These are important for cell growth and skin maintenance [<xref ref-type="bibr" rid="scirp.108071-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.108071-ref12">12</xref>]. In our study, we used umbilical cord blood-derived stem cell culture supernatant, which is rich in TGF-β. TGF-β is involved in the wound healing process such as inflammation, angiogenesis, fibroblast growth, collagen synthesis and deposition, and extracellular matrix remodeling [<xref ref-type="bibr" rid="scirp.108071-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.108071-ref14">14</xref>]. Umbilical cord blood-derived stem cell culture supernatant also contains Platelet-Derived Growth Factor (PDGF) as a main ingredient, which activates many metabolic processes such as synthesis of protein and collagen, collagenase activity, migration of fibroblasts and smooth muscle cells [<xref ref-type="bibr" rid="scirp.108071-ref15">15</xref>]. Since these growth factors are expected to improve skin such as age spots, wrinkles, and pores, we examined the effect of cosmetic Biocellshot 65. In addition to application of culture supernatant to the skin, in this study, introduction to the skin by electroporation was performed. The results were evaluated with the facial diagnostic device during three months after the start of the procedure.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Introduction Solution (Biocell Shot 65)</title><p>Biocell Shot 65 (Pure Code Inc.) contains more than 300 growth factors. In contrast, the usual agents contain only a single growth factor (see <xref ref-type="fig" rid="fig1">Figure 1</xref>). EGF is, for example, widely used in China as a burn medication or decubitus treatment. Biocell Shot 65 also contains EGF. A single application of EGF to the skin promotes the growth of epidermal cells and fibroblasts, and production of Vascular Endothelial Growth Factor (VEGF) and Hepatocyte Growth Factor (HGF) [<xref ref-type="bibr" rid="scirp.108071-ref4">4</xref>]. Biocell Shot 65 is expected to affect the skin in various ways because it contains many growth factors which have beneficial effects on the skin even with a single factor. In particular, TGF-β1 and PDGF-AA are contained in units of ng/mL, so they are expected to have a remarkable effect. TGF-β1 promotes production and deposition of extracellular matrix, and has an anti-inflammatory effect. Furthermore, it is supposed to have an anti-cancer effect, and was found first in the 33 members of the TGF family. TGF mainly acts as a modulator, and in this solution containing many growth factors, it is essential as a modulator. PDGF-AA activates hair papilla, and will work as a hair growth agent. PDGF also acts as a modulator, and is expected to suppress cell overgrowth and tumor development, with beneficial effects to modulate other growth factors. Therefore, we introduced this solution to the patients, 1 mL per application. In addition, in order to carry out the introduction more smoothly, SEREM MORE POTELE was used in combination as a solvent for Biocell Shot 65 at the same time.</p></sec><sec id="s2_2"><title>2.2. Introduction Device (BeBe Pinocchio DM-5 SUPER DX Plus)</title><p>BeBe pinocchio DM-5 SUPER DX Plus (Pure Code Inc.) is an electroporation device used on the skin (<xref ref-type="fig" rid="fig2">Figure 2</xref>). As a principle of electroporation, a sigmoidal pulse of less than 60 V leads to electrical breakdown in the keratinized layer of the skin. Immediately after the treatment, pores are observed 0.2 mm in diameter, and 0.03 mm in diameter after 5 minutes. After 10 minutes, pores close back to the original state. A high voltage of 25,000 V per cm<sup>2</sup> causes electrical breakdown and these phenomena. Also, pores in cell membranes open, so various substances can infiltrate into the skin cells [<xref ref-type="bibr" rid="scirp.108071-ref16">16</xref>]. Harue Suzuki et al. proved that hyaluronic acid of molecular weight 1,000,000 penetrates the skin with this device, therefore, the ingredients of stem cell supernatant can be introduced into skin cells with the device [<xref ref-type="bibr" rid="scirp.108071-ref17">17</xref>].</p></sec><sec id="s2_3"><title>2.3. Face Diagnostic Device (HiMirror-Professional)</title><p>HiMirror-Professional (B-by-C Inc.) is a measurement device which quantifies facial proportion with AI (<xref ref-type="fig" rid="fig3">Figure 3</xref>). It can measure and quantify stains, wrinkles, pores, etc. In this study, the actual measurement was compared with the mean ideal values by age which were calculated from the skin data of 20,000 people. The difference between the ideal value and the actual value was plotted, and a small difference represents the ideal condition. In this study, stains, wrinkles, fine lines, pores, and 4V were evaluated. 4V is a specific facial area, measured from a front photo of the face. By measuring this area, the facial proportion is quantified. It is expressed by a zone V1 where the center is the cheek, and a zone V2 where the center is the sides of the mouth. Their ratio determines the facial proportion. The cosmetic results were conventionally evaluated by impression, but 4V is one of the markers which quantifies the cosmetic result.</p></sec><sec id="s2_4"><title>2.4. Clinical Trial</title><p>The age of patients, number and content of the procedures are listed in <xref ref-type="table" rid="table1">Table 1</xref>. The patients spent their daily life in the usual way without diet or sleep restrictions. Patients were extracted from the patients visiting the clinic. Since the biocell</p><p>shot 65 used is a cosmetic product, this experiment was performed according to the guidelines established by Pure Code Co., Ltd. The patients were selected from those who agreed to this experiment among the patients who visited the clinic and those who were healthy and had no serious illness. If abnormal reactions such as skin redness were observed during the trial, it was planned to discontinue it.</p></sec><sec id="s2_5"><title>2.5. Statistical Analysis</title><p>Significant differences were obtained using the t test for equi-dispersive data, and unequal variance using the Welch t test. A p value less than 0.05 was considered statistically significant.</p></sec></sec><sec id="s3"><title>3. Results</title><p>The values for each patient were plotted (<xref ref-type="fig" rid="fig4">Figure 4</xref>). The facial photos of Patient 1 and 2 are shown with their permission (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Wrinkles, fine lines around eyes, stains, and pores in Patient 1 improved after the procedure. 4V of Patient 1 did not change. Patient 2 said that she felt the stimulation near the eyelids during the third and fifth procedure because the voltage of the device was high. However, abnormal reactions such as skin redness were not observed, so it did not affect the subsequent procedures. Fine lines around eyes improved in Patient 2, but there was no change in other items. In Patient 3, wrinkles, stains, and pores improved after the second procedure, but did not change afterwards compared with the previous skin. In Patient 4, all items except 4V improved after the fourth procedure. The mean values of all patients were plotted before and after the procedures, and there was a trend toward improvement after the procedure. However, there was no significant difference (p &gt; 0.05) (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Patient background and the procedure</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Gender</th><th align="center" valign="middle" >Age</th><th align="center" valign="middle" >Device for introducing solution</th><th align="center" valign="middle" >Solution</th><th align="center" valign="middle" >Measurement device</th><th align="center" valign="middle" >Duration of procedures</th><th align="center" valign="middle" >Number of procedures</th></tr></thead><tr><td align="center" valign="middle" >Patient 1</td><td align="center" valign="middle" >female</td><td align="center" valign="middle" >45 y.o.</td><td align="center" valign="middle" >BeBe pinocchio DM-5 SUPER DX Plus</td><td align="center" valign="middle" >M + Biocell Shot 65</td><td align="center" valign="middle" >HiMirror-Professional</td><td align="center" valign="middle" >March 24-June 13, 2020</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >Patient 2</td><td align="center" valign="middle" >female</td><td align="center" valign="middle" >49 y.o.</td><td align="center" valign="middle" >BeBe pinocchio DM-5 SUPER DX Plus</td><td align="center" valign="middle" >M + Biocell Shot 65</td><td align="center" valign="middle" >HiMirror-Professional</td><td align="center" valign="middle" >April 4-August 1, 2020</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >Patient 3</td><td align="center" valign="middle" >female</td><td align="center" valign="middle" >46 y.o.</td><td align="center" valign="middle" >BeBe pinocchio DM-5 SUPER DX Plus</td><td align="center" valign="middle" >M + Biocell Shot 65</td><td align="center" valign="middle" >HiMirror-Professional</td><td align="center" valign="middle" >June 2-August 5, 2020</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >Patient 4</td><td align="center" valign="middle" >female</td><td align="center" valign="middle" >48 y.o.</td><td align="center" valign="middle" >BeBe pinocchio DM-5 SUPER DX Plus</td><td align="center" valign="middle" >M + Biocell Shot 65</td><td align="center" valign="middle" >HiMirror-Professional</td><td align="center" valign="middle" >May 16-July 11, 2020</td><td align="center" valign="middle" >5</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><p>The stem cell culture supernatant which we used in this study contains a high concentration of TGF-β and PDGF-AA. These growth factors are expected to be introduced into the inner skin by electroporation. The molecular weight of the growth factors are 25 kDa and 28.9 kDa respectively, and the usual pore size of the skin is 50 nm, so they can be introduced by the device in this study. They are expected to act on epidermal cells and cause cascade reactions. This means that epidermal cells receive various growth factors, then, the epidermal cells produce other growth factors, activate fibroblasts and endothelial cells in the dermal layer, and promote wound healing. We performed not only simple application to the skin but also electroporation, because we needed to confirm that cascade reactions plus direct introduction of active ingredients to the dermal layer can promote collagen production. In this study, improvement of wrinkles in one month was confirmed macroscopically, and this was not done just by simple application. In the future, the introduction device and solution will be applied to a hair growth procedure. This is because the pore size of hair papilla is 300 nm, larger than the pore size of the skin, so the active ingredients can be introduced to the target site more easily. Change of the active ingredients and introduction site might lead to more effective results. In particular, for stains, introduction of anti-oxidants such as vitamin C derivatives and resveratrol, and whitening ingredients such as ascorbic acid glucoside and tranexamic acid, can cure stains more effectively. For safety, this study was performed in two once a week procedures, then every two weeks, but three or four once a week procedures, then every 10 days or every two weeks, might be better, according to the therapist. After confirming that there were no allergic reactions, more frequent use might lead to more effective results. In this study, macroscopic findings were not included in order to eliminate subjective judgement, and the items were evaluated by the skin diagnostic device with AI. This diagnostic device contains mean values and ideal values based on the skin data of approximately 20,000 people. It also has AI, and when it acquires new data, the values are renewed and the data quality improves. As data quality improves, more precise data will be expected.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In addition to application of culture supernatant to the skin, introduction to the skin by electroporation might improve stains, wrinkles, and pores. Our evaluation was performed with a facial diagnostic device three months after the start of the procedure.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Suzuki, R., Suzuki, H., Yokogawa, M. and Motohashi, J. (2021) Clinical Evaluation after Introduction of Stem Cell Supernatant Biocell Shot 65 by Electroporation. Journal of Cosmetics, Dermatological Sciences and Applications, 11, 58-70. https://doi.org/10.4236/jcdsa.2021.111006</p></sec></body><back><ref-list><title>References</title><ref id="scirp.108071-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Coutts, M., Soriano, R., Naidoo, R. and Torfi, H. (2017) Umbilical Cord Blood Stem Cell Treatment for a Patient with Psoriatic Arthritis. World Journal of Stem Cells, 9, 235-240. https://doi.org/10.4252/wjsc.v9.i12.235</mixed-citation></ref><ref id="scirp.108071-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Ueda, T., Sakai, K., Watanabe, Y. and Suzuki, H. (2009) Performance of Bipolar Electroporation Instrument and Its Improvement. Fragrance Journal, 37, 113-117.</mixed-citation></ref><ref id="scirp.108071-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Prausnitz, M.R. (1999) A Practical Assessment of Transdermal Drug Delivery by Skin Electroporation. Advanced Drug Delivery Reviews, 35, 61-76. https://doi.org/10.1016/S0169-409X(98)00063-5</mixed-citation></ref><ref id="scirp.108071-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Mineo, A., Suzuki, R. and Kuroyanagi, Y. (2013) Development of an Artificial Dermis Composed of Hyaluronic Acid and Collagen. Journal of Biomaterials Science, Polymer Edition, 24, 726-740. https://doi.org/10.1080/09205063.2012.708190</mixed-citation></ref><ref id="scirp.108071-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Nixont, C., et al. (1987) Role of Platelet-Derived Growth Factor in Wound Healing: Synergistic Effects with Other Growth Factors. Proceedings of the National Academy of Sciences of the United States of America, 84, 7696-7700. https://doi.org/10.1073/pnas.84.21.7696</mixed-citation></ref><ref id="scirp.108071-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Nall, A.V., Brownlee, R., Colvin, C.P., Schultz, G., Fein, D., Cassisi, N.J., Nguyen, T. and Kalra, A. (1996) Transforming Growth Factor Beta 1 Improves Wound Healing and Random Flap Survival in Normal and Irradiated Rats. Archives of Otolaryngology, 122, 171-177. https://doi.org/10.1001/archotol.1996.01890140057011</mixed-citation></ref><ref id="scirp.108071-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Roberts, A.B., Sporn, M.B., Assoian, R.K., Smith, J.M., Roche, N.S., Wakefield, L.M., Heine, U.I., Liotta, L.A., Falanga, V., Kehrl, J.H. and Fauci, A.S. (1986) Transforming Growth Factor-β: Rapid Induction of Fibrosis and Angiogenesis in Vivo and Stimulation of Collagen Formation in Vitro. Proceedings of the National Academy of Sciences of the United States of America, 83, 4167-4171. https://doi.org/10.1073/pnas.83.12.4167</mixed-citation></ref><ref id="scirp.108071-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Yoon, B.S., Moon, J.H., Jun, E.K., Kim, J., Maeng, I., Kim, J.S., Lee, J.H., Baik, C.S., Kim, A., Cho, K.S., Lee, J.H., Lee, H.H., Whang, K.Y. and You, S. (2010) Secretory Profiles and Wound Healing Effects of Human Amniotic Fluid-Derived Mesenchymal Stem Cells. Stem Cells and Development, 19, 887-902. https://doi.org/10.1089/scd.2009.0138</mixed-citation></ref><ref id="scirp.108071-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Kim, W.S., Park, B.S., Park, S.H., Kim, H.K. and Sung, J.H. (2009) Antiwrinkle Effect of Adipose-Derived Stem Cell: Activation of Dermal Fibroblast by Secretory Factors. Journal of Dermatological Science, 53, 96-102. https://doi.org/10.1016/j.jdermsci.2008.08.007</mixed-citation></ref><ref id="scirp.108071-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Sasaki, M., Abe, R., Fujita, Y., Ando, S., Inokuma, D. and Shimizu, H. (2008) Mesenchymal Stem Cells Are Recruited into Wounded Skin and Contribute to Wound Repair by Trans Differentiation into Multiple Skin Cell Type. The Journal of Immunology, 180, 2581-2587. https://doi.org/10.4049/jimmunol.180.4.2581</mixed-citation></ref><ref id="scirp.108071-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Kim, W.S., Park, B.S., Sung, J.H., Yang, J.M., Park, S.B., Kwak, S.J. and Park, J.S. (2007) Wound Healing Effect of Adipose-Derived Stem Cells: A Critical Role of Secretory Factors on Human Dermal Fibroblasts. Journal of Dermatological Science, 48, 15-24. https://doi.org/10.1016/j.jdermsci.2007.05.018</mixed-citation></ref><ref id="scirp.108071-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Rivers, J.K. (2014) Stem Cells for Skin Rejuvenation: Are We There Yet? Journal of Cutaneous Medicine and Surgery, 18, 75-76. https://doi.org/10.2310/7750.2014.EDIT18.2</mixed-citation></ref><ref id="scirp.108071-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Ding, D.C., Chang, Y.H., Shyu, W.C. and Lin, S.Z. (2015) Human Umbilical Cord Mesenchymal Stem Cells: A New Era for Stem Cell Therapy. Cell Transplant, 24, 339-347. https://doi.org/10.3727/096368915X686841</mixed-citation></ref><ref id="scirp.108071-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Kern, S., Eichler, H., Stoeve, J., Kluter, H. and Bieback, K. (2006) Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue. Stem Cells, 24, 1294-1301. https://doi.org/10.1634/stemcells.2005-0342</mixed-citation></ref><ref id="scirp.108071-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Jin, H.J., Bae, Y.K., Kim, M., Kwon, S.J., Jeon, H.B., Choi, S.J., Kim, S.W., Yang, Y.S., Oh, W. and Chang, J.W. (2013) Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell Therapy. International Journal of Molecular Sciences, 14, 17986-18001. https://doi.org/10.3390/ijms140917986</mixed-citation></ref><ref id="scirp.108071-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Yu, A., Takeda, A., Kumazawa, K., Miyoshi, H., Kuroyanagi, M., Yoshitake, T., Uchinuma, E., Suzuki, R. and Kuroyanagi, Y. (2015) Preliminary Clinical Study Using a Novel Wound Dressing Composed of Hyaluronic Acid and Collagen Containing EGF. Open Journal of Regenerative Medicine, 4, 6-13.</mixed-citation></ref><ref id="scirp.108071-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Rizk, M., Aziz, J., Shorr, R. and Allan, D.S. (2017) Cell-Based Therapy Using Umbilical Cord Blood for Novel Indications in Regenerative Therapy and Immune Modulation: An Updated Systematic Scoping Review of the Literature. Biology of Blood and Marrow Transplantation, 23, 1607-1613. https://doi.org/10.1016/j.bbmt.2017.05.032</mixed-citation></ref></ref-list></back></article>